Chris Shibutani Score: 24
Analyst at
Goldman Sachs,
Johnson Rice
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+5.3%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
46%
11 W / 13 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
50%
8 W / 8 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 16 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 16 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
44%
4 W / 5 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
47%
7 W / 8 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
44%
4 W / 5 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Nov 08, 2024 |
BioNTech SE - ADR
BNTX
|
BUY |
$137.00
Est. +24%
|
$110.66 | $129.27 |
Miss
|
$97.55
-11.9%
|
| Oct 30, 2024 |
Pfizer Inc.
PFE
|
BUY |
$33.00
Est. +16%
|
$28.46 | $28.64 |
Miss
|
$24.32
-14.5%
|
| Oct 16, 2024 |
Exelixis Inc
EXEL
|
SELL |
$18.00
Est. +37%
|
$28.50 | $27.86 (Low) |
Miss
|
$55.85
-96.0%
|
| Oct 16, 2024 |
Johnson & Johnson
JNJ
|
SELL |
$159.00
Est. +3%
|
$164.28 | $140.68 (Low) |
Target Met
|
$263.04
-60.1%
|
| Sep 23, 2024 |
Schrodinger Inc
SDGR
|
BUY |
$27.00
Est. +38%
|
$19.60 | $28.45 |
Target Met
|
$16.88
-13.9%
|
| Sep 04, 2024 |
Royalty Pharma plc - Ordinary Shares - Class A
RPRX
|
BUY |
$51.00
Est. +75%
|
$29.16 | $38.00 |
Miss
|
$57.77
+98.1%
|
| Aug 09, 2024 |
Lilly(Eli) & Co
LLY
|
SELL |
$856.00
Est. +4%
|
$891.68 | $623.78 (Low) |
Target Met
|
$1,210.50
-35.8%
|
| Jul 31, 2024 |
Pfizer Inc.
PFE
|
BUY |
$34.00
Est. +8%
|
$31.39 | $31.32 |
Miss
|
$24.32
-22.5%
|
| Jul 29, 2024 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$57.00
Est. +13%
|
$50.55 | $63.33 |
Target Met
|
$58.13
+15.0%
|
| Jun 07, 2024 |
Royalty Pharma plc - Ordinary Shares - Class A
RPRX
|
BUY |
$50.00
Est. +85%
|
$27.09 | $34.31 |
Miss
|
$57.77
+113.3%
|
| May 30, 2024 |
Johnson & Johnson
JNJ
|
BUY |
$160.00
Est. +11%
|
$144.44 | $169.99 |
Target Met
|
$263.04
+82.1%
|
| May 30, 2024 |
Lilly(Eli) & Co
LLY
|
SELL |
$785.00
Est. +4%
|
$818.41 | $677.09 (Low) |
Target Met
|
$1,210.50
-47.9%
|
| Apr 01, 2024 |
Erasca Inc
ERAS
|
BUY |
$7.00
Est. +217%
|
$2.21 | $3.45 |
Miss
|
$18.47
+735.7%
|
| Mar 21, 2024 |
BioNTech SE - ADR
BNTX
|
SELL |
$91.00
Est. +1%
|
$91.99 | $76.53 (Low) |
Target Met
|
$97.55
-6.0%
|
| Feb 12, 2024 |
United Therapeutics Corp
UTHR
|
BUY |
$215.00
Est. +0%
|
$214.74 | $417.82 |
Target Met
|
$555.91
+158.9%
|
| Dec 19, 2022 |
Schrodinger Inc
SDGR
|
BUY |
$23.00
Est. +12%
|
$20.54 | - | - |
$16.88
-17.8%
|
| Dec 13, 2022 |
Pfizer Inc.
PFE
|
BUY |
$60.00
Est. +12%
|
$53.37 | - | - |
$24.32
-54.4%
|
| Feb 08, 2022 |
Pfizer Inc.
PFE
|
SELL |
$50.00
Est. +3%
|
$51.70 | - | - |
$24.32
+53.0%
|
| Jan 26, 2022 |
Johnson & Johnson
JNJ
|
SELL |
$163.00
Est. +3%
|
$168.38 | - | - |
$263.04
-56.2%
|
| Dec 17, 2021 |
Lilly(Eli) & Co
LLY
|
SELL |
$236.00
Est. +11%
|
$266.31 | - | - |
$1,210.50
-354.5%
|
| Dec 17, 2021 |
Merck & Co Inc
MRK
|
BUY |
$93.00
Est. +24%
|
$75.02 | - | - |
$129.52
+72.6%
|
| May 18, 2021 |
Exelixis Inc
EXEL
|
SELL |
$23.00
Est. +6%
|
$24.34 | - | - |
$55.85
-129.5%
|
| May 18, 2021 |
Nektar Therapeutics
NKTR
|
BUY |
$24.00
Est. +32%
|
$18.13 | $19.37 |
Miss
|
$71.04
+291.8%
|
| May 18, 2021 |
Arena Pharmaceuticals Inc
ARNA
|
BUY |
$90.00
Est. +46%
|
$61.57 | - | - |
$99.99
+62.4%
|
BioNTech SE - ADR
BNTX
Nov 08, 2024
Signal & Target
BUY
$137.00
Start Price
$110.66
Best Price (1Y)
$129.27
Current Price
$97.55
Return
-11.9%
Pfizer Inc.
PFE
Oct 30, 2024
Signal & Target
BUY
$33.00
Start Price
$28.46
Best Price (1Y)
$28.64
Current Price
$24.32
Return
-14.5%
Exelixis Inc
EXEL
Oct 16, 2024
Signal & Target
SELL
$18.00
Start Price
$28.50
Best Price (1Y)
$27.86
Current Price
$55.85
Return
-96.0%
Johnson & Johnson
JNJ
Oct 16, 2024
Signal & Target
SELL
$159.00
Start Price
$164.28
Best Price (1Y)
$140.68
Current Price
$263.04
Return
-60.1%
Schrodinger Inc
SDGR
Sep 23, 2024
Signal & Target
BUY
$27.00
Start Price
$19.60
Best Price (1Y)
$28.45
Current Price
$16.88
Return
-13.9%
Royalty Pharma plc - Ordinary Shares - Class A
RPRX
Sep 04, 2024
Signal & Target
BUY
$51.00
Start Price
$29.16
Best Price (1Y)
$38.00
Current Price
$57.77
Return
+98.1%
Lilly(Eli) & Co
LLY
Aug 09, 2024
Signal & Target
SELL
$856.00
Start Price
$891.68
Best Price (1Y)
$623.78
Current Price
$1,210.50
Return
-35.8%
Pfizer Inc.
PFE
Jul 31, 2024
Signal & Target
BUY
$34.00
Start Price
$31.39
Best Price (1Y)
$31.32
Current Price
$24.32
Return
-22.5%
Bristol-Myers Squibb Co.
BMY
Jul 29, 2024
Signal & Target
BUY
$57.00
Start Price
$50.55
Best Price (1Y)
$63.33
Current Price
$58.13
Return
+15.0%
Royalty Pharma plc - Ordinary Shares - Class A
RPRX
Jun 07, 2024
Signal & Target
BUY
$50.00
Start Price
$27.09
Best Price (1Y)
$34.31
Current Price
$57.77
Return
+113.3%
Johnson & Johnson
JNJ
May 30, 2024
Signal & Target
BUY
$160.00
Start Price
$144.44
Best Price (1Y)
$169.99
Current Price
$263.04
Return
+82.1%
Lilly(Eli) & Co
LLY
May 30, 2024
Signal & Target
SELL
$785.00
Start Price
$818.41
Best Price (1Y)
$677.09
Current Price
$1,210.50
Return
-47.9%
Erasca Inc
ERAS
Apr 01, 2024
Signal & Target
BUY
$7.00
Start Price
$2.21
Best Price (1Y)
$3.45
Current Price
$18.47
Return
+735.7%
BioNTech SE - ADR
BNTX
Mar 21, 2024
Signal & Target
SELL
$91.00
Start Price
$91.99
Best Price (1Y)
$76.53
Current Price
$97.55
Return
-6.0%
United Therapeutics Corp
UTHR
Feb 12, 2024
Signal & Target
BUY
$215.00
Start Price
$214.74
Best Price (1Y)
$417.82
Current Price
$555.91
Return
+158.9%
Schrodinger Inc
SDGR
Dec 19, 2022
Signal & Target
BUY
$23.00
Start Price
$20.54
Best Price (1Y)
-
Current Price
$16.88
Return
-17.8%
Pfizer Inc.
PFE
Dec 13, 2022
Signal & Target
BUY
$60.00
Start Price
$53.37
Best Price (1Y)
-
Current Price
$24.32
Return
-54.4%
Pfizer Inc.
PFE
Feb 08, 2022
Signal & Target
SELL
$50.00
Start Price
$51.70
Best Price (1Y)
-
Current Price
$24.32
Return
+53.0%
Johnson & Johnson
JNJ
Jan 26, 2022
Signal & Target
SELL
$163.00
Start Price
$168.38
Best Price (1Y)
-
Current Price
$263.04
Return
-56.2%
Lilly(Eli) & Co
LLY
Dec 17, 2021
Signal & Target
SELL
$236.00
Start Price
$266.31
Best Price (1Y)
-
Current Price
$1,210.50
Return
-354.5%
Merck & Co Inc
MRK
Dec 17, 2021
Signal & Target
BUY
$93.00
Start Price
$75.02
Best Price (1Y)
-
Current Price
$129.52
Return
+72.6%
Exelixis Inc
EXEL
May 18, 2021
Signal & Target
SELL
$23.00
Start Price
$24.34
Best Price (1Y)
-
Current Price
$55.85
Return
-129.5%
Nektar Therapeutics
NKTR
May 18, 2021
Signal & Target
BUY
$24.00
Start Price
$18.13
Best Price (1Y)
$19.37
Current Price
$71.04
Return
+291.8%
Arena Pharmaceuticals Inc
ARNA
May 18, 2021
Signal & Target
BUY
$90.00
Start Price
$61.57
Best Price (1Y)
-
Current Price
$99.99
Return
+62.4%